A9607 Lutetium lu 177 vipivotide
Also known as: Pluvicto, Lu-177 PSMA, vipivotide
Lutetium Lu-177 vipivotide tetraxetan injection used therapeutically for treatment of prostate cancer expressing prostate-specific membrane antigen.
In Plain Language
radioactive prostate cancer treatment; targeted cancer therapy
Clinical Context
Used in targeted radiotherapy for treatment of metastatic castration-resistant prostate cancer with prostate-specific membrane antigen expression.
RVU Information
CPT A9607 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
HCPCS A-codes cover medical supplies, equipment, and transport services. Documentation must establish medical necessity and include a physician order. For durable medical equipment (DME), a Certificate of Medical Necessity (CMN) or detailed written order may be required.
Specialties
Frequently Asked Questions
What is CPT code A9607?
CPT A9607 (Lutetium lu 177 vipivotide) is a A Codes code. Lutetium Lu-177 vipivotide tetraxetan injection used therapeutically for treatment of prostate cancer expressing prostate-specific membrane antigen.
Does Medicare cover A9607?
Medicare coverage for A9607 depends on medical necessity and applicable Local Coverage Determinations (LCDs). Used in targeted radiotherapy for treatment of metastatic castration-resistant prostate cancer with prostate-specific membrane antigen expression. A physician order is typically required.
When is CPT A9607 used?
Used in targeted radiotherapy for treatment of metastatic castration-resistant prostate cancer with prostate-specific membrane antigen expression.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.